Measurement properties of the MDS-NMS Non-motor Fluctuations Subscale
Objective: This study aims at describing the measurement properties of the Non-motor Fluctuations (NMFs) subscale of the Movement Disorders Society Non-Motor Rating Scale (MDS-NMS) according…Opicapone improves motor and non-motor wearing off symptoms in Parkinson’s disease: an observational real-world study
Objective: To assess the impact of opicapone - a third generation COMT Inhibitor - on motor and non-motor wearing off symptoms in patients suffering from…Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease
Objective: To examine differences in wearing off symptoms in Parkinson’s Disease (PD) according to gender, age, and age at PD diagnosis. Background: Off symptoms in…Exploring the relationship between motor and non-motor fluctuations in Parkinson’s disease: patient’s perspective, clinician’ s assessment and objective measures from a wearable device
Objective: We aimed: 1) To evaluate the relationship between motor (MF) and non-motor (NMF) fluctuations in Parkinson’s disease measured with patient’s self-assessment, clinician’s evaluationand objective measurement using a wearable…Polyneuropathy in patients with continuous levodopa/carbidopa intestinal gel (LCIG) infusion
Objective: To assess frequency of polyneuropathy in patients with LCIG and the usefulness of routine nerve conduction studies follow-up Background: Continuous levodopa infusion is an…Do non-motor fluctuations temporarily match ON/OFF motor condition?
Objective: The aim of this study was to explore the relation between non-motor neuropsychological fluctuations, identified with the Neuropsychiatric Fluctuation Scale (NFS), and motor fluctuations…BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson’s disease
Objective: Determine the efficacy, safety, and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral Carbidopa/Levodopa (CD/LD) in patients with Parkinson’s disease (PD) experiencing…Real-life gait performance as a marker for motor fluctuations: the Parkinson@home Validation study
Objective: To assess the feasibility of using real-life gait performance derived from a single wearable as a marker for motor fluctuations in Parkinson’s disease (PD).…Addition of Opicapone to Safinamide in Parkinson’s Disease patients
Objective: To assess safety and efficacy of Opicapone in patients treated with Levodopa and Safinamide presenting early morning “off” states and akinesia. Background: Safinamide is…Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson’s Disease and “OFF” Episodes: Post Hoc Analysis From a Phase 3 Study
Objective: To compare time to onset and magnitude of motor improvement following administration of apomorphine sublingual film (APL-130277; APL) vs levodopa in patients with Parkinson’s…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 26
- Next Page »